Caris Life Sciences Rallies 10% as Precision Oncology Sector Gains Momentum
Caris Life Sciences shares climbed 10% in a sector-wide rally, leaving the stock trading above analyst price targets as investors weigh decelerating…
Caris Life Sciences shares climbed 10% in a sector-wide rally, leaving the stock trading above analyst price targets as investors weigh decelerating…
BlossomHill Therapeutics stock gains 4.4% as the company reports a 45% objective response rate for its BH-30643 lung cancer treatment in the…
Geron reports record quarterly revenue of $57.5 million and raises its 2026 RYTELO revenue guidance to $230M-$240M as the company accelerates its…
Champions Oncology posted a 9% revenue increase to $15.2 million in Q1 fiscal 2027, driven by improved service margins and a surge…
Moderna stock maintains strong bullish momentum, surging 499.5% annually after its cancer vaccine trial met key clinical goals, leaving sector peers like…